- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. freshman Good
|
- 10-K Annual report
- 10.13.4 Partial Lease Termination Agreement
- 10.27.3 Amendment No. 2 to Loan and Security Agreement
- 10.33.1 Collaboration, Liscense and Supply Agreement
- 10.33.2 Amendment to Collaboration, License and Supply Agreement
- 21.1 Subsidiaries of Registrant
- 23.1 Consent of Independent Registered Public Accounting Firm
- 31.1 Section 302 Certification of CEO
- 31.2 Section 302 Cerification of Pfo
- 32.1 Section 906 Certifications of CEO and Pfo
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We consent to the incorporation by reference in the Registration Statements on Form S-8 (Nos. 333-132593, 333-141718, 333-149129, 333-151303, 333-162485, 333-164843, 333-171604 and 333-176173) pertaining to the 2005 Equity Incentive Plan, 2005 Non-Employee Directors’ Stock Option Plan and 2005 Employee Stock Purchase Plan of Alexza Pharmaceuticals, Inc. and the Registration Statements on Form S-3 (Nos. 333-161804, 333-162582, 333-166514, and 333-169649) and the related prospectuses of Alexza Pharmaceuticals, Inc. of our reports dated March 12, 2012, with respect to the consolidated financial statements of Alexza Pharmaceuticals, Inc. and the effectiveness of internal control over financial reporting of Alexza Pharmaceuticals, Inc., included in this Annual Report (Form 10-K) for the year ended December 31, 2011.
/s/ Ernst & Young LLP
Redwood City, California
March 12, 2012